Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Johanna Heugenhauser"'
Autor:
Martha Nowosielski, Georg Goebel, Sarah Iglseder, Ruth Steiger, Lukas Ritter, Daniel Stampfl, Johanna Heugenhauser, Johannes Kerschbaumer, Elke R. Gizewski, Christian F. Freyschlag, Guenther Stockhammer, Christoph Scherfler
Publikováno v:
Clinicalexperimental metastasis. 39(3)
Aims In this retrospective study we performed a quantitative textural analysis of apparant diffusion coefficient (ADC) images derived from diffusion weighted MRI (DW-MRI) of single brain metastases (BM) patients from different primary tumors and test
Autor:
Sarah Iglseder, Martha Nowosielski, Gabriel Bsteh, Armin Muigg, Johanna Heugenhauser, Elke Mayer, Astrid Grams, Günther Stockhammer, Meinhard Nevinny-Stickel
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 198(5)
Background Although there is no proven standard therapy for leptomeningeal metastases (LM), treatment often includes intrathecal chemotherapy combined with whole brain radiation therapy (WBRT). Little is known about the toxicity of such combination t
Autor:
Elke Mayer, Astrid E. Grams, Armin Muigg, Martha Nowosielski, Guenther Stockhammer, Sarah Iglseder, Gabriel Bsteh, Johanna Heugenhauser, Meinhard Nevinny-Stickel
Publikováno v:
Neuro Oncol
BACKGROUND Although there is no proven standard therapy for leptomeningeal metastases (LM), treatment often includes intrathecal chemotherapy combined with whole brain radiation therapy (WBRT). Little is known on the toxicity of such combination ther
Autor:
Johanna Heugenhauser, Malik Galijasevic, Stephanie Mangesius, Georg Goebel, Johanna Buchroithner, Friedrich Erhart, Josef Pichler, Georg Widhalm, Günther Stockhammer, Sarah Iglseder, Christian F. Freyschlag, Stefan Oberndorfer, Karin Bordihn, Gord von Campe, Thomas Czech, Birgit Surböck, Tadeja Urbanic Purkart, Christine Marosi, Thomas Felzmann, Martha Nowosielski
Publikováno v:
Cancers; Volume 14; Issue 6; Pages: 1579
Introduction: In this post hoc analysis we compared various response-assessment criteria in newly diagnosed glioblastoma (GB) patients treated with tumor lysate-charged autologous dendritic cells (Audencel) and determined the differences in predictio